Lilly to buy European ADC biotech; AbbVie ends SHP2 work with Jacobio
Eli Lilly acquired all shares of Emergence Therapeutics, Heidelberg Pharma said last week.
The German pharmaceutical company was a minor shareholder in Emergence, a biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.